Acquiring Company
Scipher Medicine
Acquired Company
Chemomab Therapeutics Ltd
Waltham
Tel AvivBiotechnologyHealth CareMedicalTherapeuticsBiotechnologyHealth CareTherapeuticsDescription
Chemomab Therapeutics and Scipher Medicine announced a definitive merger agreement to combine their operations. The newly formed entity will be named Scipher Medicine Corporation and will focus on advancing the clinical stage anti-CCL24 antibody, nebokitug, into a Phase 2 trial for rheumatoid arthritis. The merger aims to leverage each company's strengths in precision medicine and improve treatment for patients. The combined company is expected to be valued at $150 million.
Who to call at Scipher Medicine, and when
When Scipher Medicine changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Scipher Medicine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Scipher Medicine, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Scipher Medicine makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Chemomab Therapeutics Ltd?
Chemomab Therapeutics Ltd was acquired by Scipher Medicine, based in Waltham. The deal was reported on July 8, 2026. Scipher Medicine, a precision immunology company matching patients with their most effective therapy, believes that patients deserve simple answers to treatment options based on scientific data. Scipher Medicine is privately held and operates in Biotechnology.
When did Scipher Medicine acquire Chemomab Therapeutics Ltd?
Scipher Medicine's acquisition of Chemomab Therapeutics Ltd was reported on July 8, 2026. Chemomab Therapeutics and Scipher Medicine announced a definitive merger agreement to combine their operations. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Chemomab Therapeutics Ltd do?
Chemomab is a clinical stage biotechnology company discovering and developing innovative therapeutics for fibro-inflammatory diseases with high unmet need. It is publicly traded (CMMB), operating in Biotechnology, and is based in Tel Aviv.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.